Glaxo and Novartis to swap assets in major three-part deal

14:12 PM | April 28, 2014 | —Natasha Alperowicz

GlaxoSmithKline (GSK) has announced a major, three-part transaction with Novartis involving its consumer health-care, vaccines, and oncology businesses. GSK and Novartis, as part of the transaction,...